Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
Telos Corp
NASDAQ:TLS
|
US |
|
L
|
Laurent Perrier SA
F:LPE
|
FR |
|
4
|
4C Group AB
F:K0E
|
SE |
|
Mckesson Corp
NYSE:MCK
|
US |
|
Abliva AB
STO:ABLI
|
SE |
|
Bharat Heavy Electricals Ltd
NSE:BHEL
|
IN |
|
Churchill Capital Corp VII
NASDAQ:CVII
|
US |
|
C
|
Compal Electronics Inc
TWSE:2324
|
TW |
|
CJ Corp
KRX:001040
|
KR |
Wall St Price Targets
SWOBY Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for SWOBY is 23.66 USD with a low forecast of 15.78 USD and a high forecast of 28.22 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SWOBY's stock price target?
Price Target
23.66
USD
According to Wall Street analysts, the average 1-year price target for SWOBY is 23.66 USD with a low forecast of 15.78 USD and a high forecast of 28.22 USD.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
50%
The compound annual growth rate for Net Income over the next 8 years is 50%.
